Topical treatments such as corticosteroids may be prescribed by your pediatrician to relieve symptoms. Papular urticaria is a hypersensitivity to insect bites, often from mosquitoes, bedbugs, fleas, ...

Papular urticaria is a hypersensitivity to insect bites, often from mosquitoes, bedbugs, fleas, or mites. It’s especially common in toddlers and young children. Common symptoms are extremely red ...

Management of urticaria de pends on its cause. Aggravating factors should be identified from the history, and triggering stimuli for physical urticaria avoided. Simple cooling lotions, as 0.5% to ...

Urticarial vasculitis represents 5% to 10% of cases of chronic urticaria, characterized histologically by the presence of vasculitis on skin biopsy. Clinically it tends to last longer than ...

In another top story, results from the randomized BEACON trial revealed that adults with moderate to severe chronic spontaneous urticaria saw substantial reductions in tryptase as early as week 1 ...

ABSTRACT The aim of this study was to compare the in vitro activity of delafloxacin with other fluoro-quinolones against bacterial pathogens recovered from inpatients with osteomyelitis, Acute ...

Hives, also called urticaria, are red, itchy welts that can appear anywhere on the body and range from mild to severe. In darker skin tones, they may appear as a patch of skin slightly darker than the ...

Dyshidrotic eczema is a type of eczema that produces skin blisters on the feet and hands. Some people refer to these blisters as stress bumps, although this is not a medical term. Doctors may also ...

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Johnson & Johnson has announced its acquisition of Intra-Cellular Therapies for approximately $14.6 billion, paying $132 per share in cash. The acquisition includes CAPLYTA® (lumateperone), the ...

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...